FDA Import Refusal 1FX-8809105-3/10002/1 — IND SWIFT LIMITED

IND SWIFT LIMITED — FEI 3016800546

The FDA refused shipment 1FX-8809105-3/10002/1 from IND SWIFT LIMITED (India) on Oct 5, 2026. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charges: 9999978,9999978,9999979,9999979 This firm has 1 other import refusal on record.

Refusal Details

Date
Oct 5, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61PDA68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
Charges
9999978,9999978,9999979,9999979

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.